Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like As Its CEO Retires, Cerecor Divests Depression Drug to Pharma Giant in $45 Million Deal August 14, 2017 GlaxoSmithKline Ditches Ionis Pharma's Inotersen and IONIS-FB-LRx August 10, 2017 Siemens Summons Three Banks for IPO of Healthineers Unit October 25, 2017
As Its CEO Retires, Cerecor Divests Depression Drug to Pharma Giant in $45 Million Deal August 14, 2017